Aspire HD Plus, Aspire HD-s (for FDR-2000AWS) The Fujifilm Digital Mammography Systems, Aspir...

FDA Device Recall #Z-0660-2018 — Class II — August 4, 2017

Recall Summary

Recall Number Z-0660-2018
Classification Class II — Moderate risk
Date Initiated August 4, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Fujifilm Medical Systems U.S.A., Inc.
Location Stamford, CT
Product Type Devices
Quantity 71 units (68 units Domestic. 3 units Foreign) in total

Product Description

Aspire HD Plus, Aspire HD-s (for FDR-2000AWS) The Fujifilm Digital Mammography Systems, Aspire HD Plus (FDR MS-2500) and Aspire ND-s (FDR MS-2000), generate full-field digital mammography images that can, as other full-field digital mammography systems, be used for screening and diagnosis of breast cancer and are intended for use in the same clinical applications as traditional screen-film mammography systems.

Reason for Recall

FUJIFILM Medical Systems U.S.A., Inc. (FMSU) identified a potential failure with our Mammography system. The acquisition workstations, FDR¿1000AWS, FDR-2000AWS, FDR-3000AWS, and CR¿IR363AWS assign a unique ID number to every image study but very rarely, with the acquisition workstation software versions, VS.O, VS.1, VS.2 , V6.0, V6.1, and V7.0, the system may assign the same ID number to a new set of images that was already assigned to the previous set of images due to the error in ID number generation logic. If an Image with this error (with duplicate ID number) Is transmitted to PACS, it may overwrite the image already stored on PACS.

Distribution Pattern

Worldwide Distribution.

Lot / Code Information

2000AWS. Released Software Versions: V5.1, V6.0, V6.1. Not Released Software Versions: V5.0, V5.2, V7.0.

Other Recalls from Fujifilm Medical Systems U.S.A., Inc.

Recall # Classification Product Date
Z-1775-2021 Class II Synapse Cardiovascular (Synapse CV). Software... Apr 30, 2021
Z-1348-2021 Class II Synapse PACS - Radiological Image Processing Sy... Mar 2, 2021
Z-1412-2021 Class II ¿TASWako Chip Cassette is part of the Wako ¿TAS... Feb 18, 2021
Z-0932-2021 Class III Wako HDL-C/LDL-C Calibrator - Product Usage: de... Dec 22, 2020
Z-0918-2021 Class II FUJIFILM Synapse PACS Software: versions 7.0.0 ... Dec 11, 2020

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.